Cardiac resynchronization therapy (CRT) in heart failure - A model to assess the economic value of this new medical technology

Value in Health

Volumn 8, Issue 2, 2005, Pages 128-139

  Banz, Kurt ^a,b  

^a Outcomes International   (Switzerland)

^b Outcomes International   (Switzerland)

Author keywords

Biventricular pacing; Cardiac resynchronization therapy; Cost effectiveness; CRT; Economic; Heart failure; Model

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION MAKING; DIAGNOSIS RELATED GROUP; DISEASE SEVERITY; GERMANY; HEALTH CARE COST; HEART FAILURE; HOSPITALIZATION; HUMAN; MEDICAL TECHNOLOGY; MODEL; MONEY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT;

EID: 17144379282     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2005.03092.x     Document Type: Article

References (40)

1. McKee PA, Castelli PW, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
2. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Fur Heart J 1997;18:208-25.
3. McMurray J, McDonagh T, Morrison CE, et al. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993;14:1158-62.
4. Cleland JG, Gemmell I, Khand A, et al. Is the prognosis of heart failure improving? Eur J Heart Fail 1999;1:229-41.
5. McAlister FA, Teo KK, Taher M, et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 1999;138:87-94.
6. Cowie MR, Wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000;83:505-10.
7. Notheis W. Biventrikuläre Stimulation bei Patienten Mit Chronischer Herzinsuffizienz. München: W. Zuckschwerdt Verlag, 2001.
8. American Heart Association, 1999. Heart and Stroke Statistical Update. Dallas: American Heart Association, 1998.
9. Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990;38:1290-5.
10. Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail 2001;3:283-91.
11. Petersen S, Rayner M. Coronary Heart Disease Statistics: Heart Failure Supplement. London: British Heart Foundation, 2002.
12. Rickenbacher P. Herzinsuffizienz: Epidemiologie, Pathophysiologie. Swiss Medical Forum No. 1/2, January 2001.
13. Teo KK, Ignaszewski AP, Guiterrez R, et al. Contemporary medical management of left ventricular dysfunction and congestive heart failure. Can J Cardiol 1992;8:611-19.
14. Kjekshus J, Swedberg K, Snapinn S. Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS Trial Group. Am J Cardiol 1992;69:103-7.
15. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
16. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
17. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002;106:2194-9.
18. Chow AWC, Lane RE, Cowie MR. New pacing technologies for heart failure. BMJ 2003;326:1073-7.
19. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
20. Auricchio A, Stellbrink C, Sack S, et al. Long term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;29:2026-33.
21. Braunschweig F, Linde C, Gadler F, et al. Reduction of hospital days by biventricular pacing. Eur J Heart Fail 2000;2:399-406.
22. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation In Cardiomyophathy (MUSTIC) Study. J Am Coll Cardiol 2002;40:111-18.
23. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
24. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized controlled trials. JAMA 2003;289:730-40.
25. Ricci R, Ansalone G, Toscano S, et al. Cardiac resynchronization: materials, technique and results. The InSync Italian Registry. Eur Heart J 2000;2(Suppl. J):S6-15.
26. Pürerfellner H, Nesser HJ, Winter S, et al. Transvenous left ventricular lead implantation with the EASYTRAK lead system. The European experience. Am J Cardiol 2000;86(Suppl.):S157-64.
27. Curnis A, Caprari F, Mascioli G, et al. Valutazione economica della resincronizzazione cardiaca nei pazienti affetti da scompenso cardiaco moderato-avanzato. Risultati dello studio BRESCIA. Pharmacoeconomics 2003;5:11-22.
28. Zardini M, Tritto M, Bargiggia G, et al. The InSync Italian Registry: analysis of clinical outcome and considerations on the selection of candidates to left ventricular resynchronization. Eur Hear J 2000;2(Suppl. J):S16-22.
29. Gras D, Leclercq C, Tang A, et al. Cardiac resynchronization therapy in advanced heart failure: the multicenter InSync clinical study. Eur J Heart Fail 2002;4:311-20.
30. Lewis EF, Johnson PA, Johnson W, et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001;20:1016-24.
31. Statistisches Taschenbuch Gesundheit. Bundesministerium für Gesundheit: Bonn, Germany, 2002.
32. Wezel H, Liebold R. Einheitlicher Bewertungsmassstab für ärztliche Leistungen (EBM) 2002. Sankt Augustin: Asgard-Verlag, Dr. Werner Hippe GmbH, 2002.
33. Rote Liste. Editio Cantor Verlag GmbH. Aulendorf: 2002.
34. Dixon LJ, Thompson G, Harbinson M, et al. Cardicac resynchronisation therapy-a cost effective treatment for cardiac failure. Eur Heart J 2002;4:3.
35. Evans C, Tavakoli M, Crawford B. Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal. Health Care Manag Sci 2004;7:43-9.
36. Bentkover JD, Stewart EJ, Ignaszewski A, et al. New technologies and potential cost savings related to morbidity and mortality reduction in Class III/IV heart failure patients in Canada. Int J Cardiol 2003;88:33-41.
37. Leclercq C, Linde C, Cazeau S, et al. Sustained clinical efficacy of biventricular pacing in sinus rhythm patients: 2 years follow-up from the MUSTIC study. Eur Heart J 2002;4:3.
38. Cowie MR, Fox KF, Wood DA, et al. Hospitalisation of patients with heart failure. Eur Heart J 2002;23:877-85.
39. Salukhe TV, Francis DP, Sutton R. Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization. Int J Cardiol 2003;87:119-20.
40. Krankheitsartenstatistik 1998. Bonn: AOK Bundesverband, 2002.